Generating data packages to maximize the value of therapeutic antibody assets

The commercialization of innovative antibody therapeutics needs significant capital investments to fund pre-clinical and clinical studies. Many small biotech that are focused on development lack these resources and the infrastructure needed to launch new biologics. Forming partnerships with larger pharmaceutical companies is one strategy that provides access to the resources needed for later stage development but partnering companies will want to scrutinize the data behind the candidate molecule. For this reason, it is crucial for a biotech company to understand the data packages that need to be generated. These will need to show that the biotech company can meet the necessary regulatory requirements but also answer other key questions that potential development and/or exit partners will have. In this webinar, we will provide a general overview of both areas.

Live Webcast Information
Start Time:
October 28, 2021 11:00 AM Eastern
10:00 AM Central, 9:00 AM Mountain, 8:00 AM Pacific
Add to Calendar:
Estimated Length:
1 hour
Registration Time Remaining:
7 days, 13 hours
Registration Fee:
Free
Register Now
In order to access this program after registering, a TAS account will be provided for you based on the information you have entered.

To access your account after your purchase, use the My Account links on the left hand side of this page to login using the information your provide here.
According to our records there is already a TAS account using the email address you have provided.

To continue with your registration please enter your account password. If you do not know your account password you can retrieve it here: Forgot Password?
First Name:
Last Name:
Email:
Confirm Email:
Organization:
Country:
The email address you have entered has an existing TAS account.

Please enter your password in the field below. Forgot Password?

Email:
Password:
Country:
Billing Address:
City:
State:
State/Province:
Zip:
Expiration: 
Generating data packages to maximize the value of therapeutic antibody assets

The commercialization of innovative antibody therapeutics needs significant capital investments to fund pre-clinical and clinical studies. Many small biotech that are focused on development lack these resources and the infrastructure needed to launch new biologics. Forming partnerships with larger pharmaceutical companies is one strategy that provides access to the resources needed for later stage development but partnering companies will want to scrutinize the data behind the candidate molecule. For this reason, it is crucial for a biotech company to understand the data packages that need to be generated. These will need to show that the biotech company can meet the necessary regulatory requirements but also answer other key questions that potential development and/or exit partners will have. In this webinar, we will provide a general overview of both areas.

Speaker Information
Bjoern Cochlovius  [ view bio ]
Individual topic purchase: Selected